Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2018 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2018 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
< 0.001 |
1 |
|
2012 |
2012 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Alveolar Bone Loss
|
disease |
Musculoskeletal Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
101
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
androgen independent prostate cancer
|
disease |
|
Neoplastic Process
|
190
|
5
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
1410
|
80
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Arthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1072
|
69
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2015 |
Asthma, Aspirin-Induced
|
disease |
Respiratory Tract Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
25
|
6
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
985
|
59
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Ataxia Telangiectasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
384
|
698
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Autism Spectrum Disorders
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1071
|
331
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Barrett Esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
478
|
60
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2012 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.100 |
None |
1.000 |
18 |
|
2005 |
2020 |
Breast Diseases
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
73
|
6
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2007 |
Breast Fibrocystic Disease
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
114
|
12
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
11 |
|
2006 |
2018 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.040 |
None |
1.000 |
4 |
|
2000 |
2014 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |